Evidence map›Paper›PMID 36928230›Full record

ArticlePloS one2023

Comparison of a machine and deep learning model for automated tumor annotation on digitized whole slide prostate cancer histology.

Savannah R Duenweg, Michael Brehler, Samuel A Bobholz, Allison K Lowman, Aleksandra Winiarz, Fitzgerald Kyereme, Andrew Nencka, Kenneth A Iczkowski, Peter S LaViolette

Full text read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Applications of artificial intelligence in urologic oncology.Investigative and clinical urology · 2024
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Savannah R DuenwegDepartment of Biophysics, Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America.ORCID 0000-0003-4010-7737
Michael BrehlerDepartment of Radiology, Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America.
Samuel A BobholzDepartment of Biophysics, Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America.
Allison K LowmanDepartment of Radiology, Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America.
Aleksandra WiniarzDepartment of Biophysics, Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America.
Fitzgerald KyeremeDepartment of Radiology, Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America.
Andrew NenckaDepartment of Radiology, Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America.
Kenneth A IczkowskiDepartment of Pathology, Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America.
Peter S LaVioletteDepartment of Radiology, Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America.ORCID 0000-0002-9602-6891

Funding

Prostate Cancer Radio-Pathomics for Differentiating Clinically Significant DiseaseR01CA249882 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI LAVIOLETTE, PETER S · 2021 to 2025
$3.0M
Brain Cancer Radio-Pathomics for Predicting Heterogeneous CytologyR01CA218144 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI LAVIOLETTE, PETER S · 2017 to 2021
$1.9M
Bayesian learning algorithms for identifying and classifying heterogeneity of cell types in variety of solid tumorsR21CA231892 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI BANERJEE, ANJISHNU · 2018 to 2019
$362k
NCI NIH HHS R01 CA218144NCI NIH HHS R01 CA249882NCI NIH HHS R21 CA231892
6 · The paper itself

Abstract

One in eight men will be affected by prostate cancer (PCa) in their lives. While the current clinical standard prognostic marker for PCa is the Gleason score, it is subject to inter-reviewer variability. This study compares two machine learning methods for discriminating between cancerous regions on digitized histology from 47 PCa patients. Whole-slide images were annotated by a GU fellowship-trained pathologist for each Gleason pattern. High-resolution tiles were extracted from annotated and unlabeled tissue. Patients were separated into a training set of 31 patients (Cohort A, n = 9345 tiles) and a testing cohort of 16 patients (Cohort B, n = 4375 tiles). Tiles from Cohort A were used to train a ResNet model, and glands from these tiles were segmented to calculate pathomic features to train a bagged ensemble model to discriminate tumors as (1) cancer and noncancer, (2) high- and low-grade cancer from noncancer, and (3) all Gleason patterns. The outputs of these models were compared to ground-truth pathologist annotations. The ensemble and ResNet models had overall accuracies of 89% and 88%, respectively, at predicting cancer from noncancer. The ResNet model was additionally able to differentiate Gleason patterns on data from Cohort B while the ensemble model was not. Our results suggest that quantitative pathomic features calculated from PCa histology can distinguish regions of cancer; however, texture features captured by deep learning frameworks better differentiate unique Gleason patterns.

Indexed as

Deep LearningProstatic NeoplasmsHumansMachine LearningMaleNeoplasm GradingPrognosisProstate

Identifiers

PMID36928230
PMCPMC10019669

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read28
identifiers read7
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.